Table 3.

(Serious) adverse events

Serious adverse events	n = 1 pneumocystis jerovici pneumonia (2 mo after start) n = 1 pneumosepsis (3 mo after start) n = 1 Influenza A (2 mo after start) n = 1 pulmonary embolism (1 mo after start)
Adverse events	n = 6 leukopenia n = 1 liver test abnormalities n = 1 urinary tract infection n = 3 poor sleep quality n = 2 loss of hair n = 2 nausea n = 1 low IgG